NCT02094716View on ClinicalTrials.gov

A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Scabies
Interventions
DRUG

Permethrin Foam 4%

Topical application, whole-body treatment

DRUG

Permethrin Foam 5%

Topical application, whole-body treatment

DRUG

Vehicle Foam

Topical application, whole-body treatment

Trial Locations (9)

10018

Clinical Research Site, New York

19103

Clinical Research Site, Philadelphia

33016

Clinical Research Site, Hialeah

90036

Clinical Research Site, Los Angeles

94538

Clinical Research Site, Fremont

Unknown

Clinical Research Site, San Cristóbal

Clinical Research Site, Santo Domingo

Clinical Research Site, San Pedro Sula

00716

Clinical Research Site, Ponce

Sponsors

Lead Sponsor

Mylan Inc.

Collaborators (1)

DPT Laboratories, Ltd.
All Listed Sponsors
collaborator

DPT Laboratories, Ltd.

INDUSTRY

collaborator

Vyne Therapeutics Inc.

INDUSTRY

lead

Mylan Inc.

INDUSTRY

NCT02094716 - A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies | Biotech Hunter | Biotech Hunter